Research on expression of SPAG9 and anti-SPAG9 autoantibody in peripheral blood with testicular fine needle aspiration

Status

Recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-CPC-14005382

Enrollment

Unknown

Registered

2014-09-03

Start date

2014-09-03

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Male infertility

Interventions

Case series:Testis puncture

Eligibility

Sex/Gender

Male

Age

19 Years to 40 Years

Inclusion criteria

Inclusion criteria: Testis puncture patients

Exclusion criteria

Exclusion criteria: Testicular injury patients.

Design outcomes

Primary

Measure	Time frame
SPAG9;anti-SPAG9 autoantibody;	—

Contacts

Public ContactJun-ping Xing

xingjpcn@yahoo.com.cn+86 13008403189

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026